What is NDC 51662-1548?

51662-1548 is the product NDC for Verapamil Hci, Verapamil hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Verapamil Hci?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Verapamil Hci NDC 51662-1548 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1548Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1548Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1548-1	5166215480151662154801	4 mL in 1 VIAL, SINGLE-DOSE (51662-1548-1)Marketed from May 20, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hci
Generic name (nonproprietary): verapamil hci
Active ingredients: Verapamil hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212965
Marketing start: May 20, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 51662-1548_df7a677c-e654-5f4b-e053-2995a90a06b3SPL ID df7a677c-e654-5f4b-e053-2995a90a06b3SPL set ID df786377-7d2c-249b-e053-2a95a90aab22RxCUI 1665061UNII V3888OEY5RUPC 0355150343010
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662154801 followed by a unit qualifier and the quantity

Package 51662-1548-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 20, 2022.

Indications (excerpt from the label)

INDICATIONS & USAGE Verapamil hydrochloride injection, USP is indicated for the following: Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [W-P-W] and Lown-Ganong- Levine [L-G-L] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson-White (W-P-W) and Lown-Ganong-Levine (L-G-L) s…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1548

What is NDC 51662-1548?: 51662-1548 is the product NDC for Verapamil Hci, Verapamil hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Verapamil Hci.
What is the active ingredient?: Verapamil hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Verapamil Hci?: 2 other product NDCs are listed under this name. See all Verapamil Hci NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Verapamil Hci NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Verapamil Hci	Verapamil hydrochloride 2.5 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1442	51662-1442-01
Verapamil Hci	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1269	51662-1269-0151662-1269-0251662-1269-03

Other NDCs under ANDA 212965

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212965
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1549
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Eugia US LLC	55150-342
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Eugia US LLC	55150-343